Trovafloxacin is active against Toxoplasma gondii.
Drugs currently used for treatment of toxoplasmosis in pregnant women, congenital infections, immunocompromised patients, and patients with the ocular disease are not always effective or may be dangerous to use; therefore, there is a need for more-effective and less-toxic drugs. Recently, we examine...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1996
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163429/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8843293/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.8.1855 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|